Search results
Results From The WOW.Com Content Network
[89] [90] [91] Selective serotonin reuptake inhibitors are first-line medications for OCD in children with established AACAP guidelines for dosing. [92] Medication in addition to a CBT intervention like exposure and response prevention (ERP) is more beneficial than only using medication in the treatment of OCD in children. [93]
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes).This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology § List of abbreviations for those).
Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class [2] used for the treatment of major depressive disorder, anxiety, obsessive–compulsive disorder (OCD), panic disorder, premenstrual dysphoric disorder, and bulimia nervosa. [2]
Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [8] It is primarily used to treat major depressive disorder and, perhaps more-especially, obsessive–compulsive disorder (OCD), [9] but is also used to treat anxiety disorders [10] such as panic disorder, social anxiety disorder, and post-traumatic stress ...
Obsessive–compulsive personality disorder (OCPD), a mental disorder that is often mistakenly called OCD; On-call duty, a long shift that may be assigned to medical residents; Ortho-Clinical Diagnostics, an American company; Osteochondritis dissecans, a painful joint condition in humans and other animals
The therapeutic response does not seek to answer the question but to accept the uncertainty of the unsolved dilemma. Acceptance and commitment therapy (ACT) is a newer approach that also is used to treat primarily obsessional OCD, as well as other mental disorders such as anxiety and clinical depression.
Perphenazine is used to treat psychosis (e.g. in people with schizophrenia and the manic phases of bipolar disorder and OCD). Perphenazine effectively treats the positive symptoms of schizophrenia, such as hallucinations and delusions, but its effectiveness in treating the negative symptoms of schizophrenia, such as flattened affect and poverty of speech, is unclear.
Off-label uses include treatments for attention-deficit hyperactivity disorder (ADHD), and obsessive–compulsive disorder (OCD). [1] SNRIs are monoamine reuptake inhibitors; specifically, they inhibit the reuptake of serotonin and norepinephrine. These neurotransmitters are thought to play an important role in mood regulation.